Neuralstem Inc. | Ownership
Companies that own Neuralstem Inc.
The Vanguard Group, Inc.
521,661
3.44%
-32,273
0%
06/30/2018
Alethea Capital Management LLC
164,394
1.09%
0
0.32%
06/30/2018
William Blair Investment Management LLC
87,343
0.57%
0
0%
06/30/2018
Geode Capital Management LLC
83,079
0.55%
0
0%
06/30/2018
BlackRock Fund Advisors
70,154
0.46%
-25,648
0%
06/30/2018
PanAgora Asset Management, Inc.
31,423
0.21%
1,892
0%
06/30/2018
Northern Trust Investments, Inc.
25,975
0.17%
0
0%
06/30/2018
Dimensional Fund Advisors LP
21,044
0.14%
0
0%
06/30/2018
Virtu Financial BD LLC
20,962
0.14%
20,962
0%
06/30/2018
National Asset Management, Inc.
19,485
0.13%
1,200
0%
03/31/2018
| Address |
20271 Goldenrod Lane
Germantown Maryland 20876
United States
|
|
Employees
|
- |
| Website |
http://www.neuralstem.com |
| Updated |
07/08/2019 |
| Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. |
